在骨关节炎患病率,疼痛感知,身体功能和治疗方法方面的性别差异
Neil A Segal1, Jeannine M Nilges2, Win Min Oo3
1University of Kansas Medical Center, Kansas City, KS, USA; The University of Iowa, Iowa City, IA, USA.
Osteoarthritis and cartilage
|April 8, 2024
概括
女性患关节炎的发病率更高,结果更差,比男性更为严重. 研究强调了OA风险,疼痛,功能和治疗反应的性别特异性差异,需要量身定制的方法.
科学领域:
- 风湿病学和整形外科
- 基于性别的医学
- 疼痛研究 疼痛研究
背景情况:
- 骨关节炎 (OA) 对女性的影响不成比例,与男性相比,患病率更高,临床过程更严重.
- 现有的研究不足地解决了与OA这些性别特异性差异相关的潜在因素和治疗结果.
研究的目的:
- 审查有关骨关节炎 (OA) 患病率,风险因素,疼痛,功能结果和治疗反应的性别差异的当前知识.
- 突出需要在OA研究和治疗中考虑性别特异性.
主要方法:
- 使用PubMed使用关键词"性别或性"和"骨关节炎"进行了全面的文献搜索.
- 最初的搜索结果显示了212个参考文献,另外343篇论文被审查了相关性和包含性.
主要成果:
- 女性占OA患者的60%,在40岁以后差距会扩大.
- 导致女性关节风险的性别特异性因素包括关节解剖学,荷尔蒙影响,肥胖和遗传学.
- 妇女报告的疼痛严重程度和功能限制比男性更大,具有相当的放射性OA严重程度,可能是由于不同的疼痛途径和应对策略.
- 妇女使用更多的止痛药,但接受的关节整形手术较少,经历手术后的结果较差.
结论:
- 在OA中认识到性别差异对于开发量身定制的,性别特定的治疗方案至关重要.
- 将性别作为生物变量的分析纳入未来的研究对于在OA管理中推进精准医学至关重要.
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614


